Conversion from calcineurin inhibitors to sirolimus improves renal function in heart transplant recipients with de novo renal dysfunction

被引:0
|
作者
El-Hamamsy, I. [1 ]
Stevens, L. M. [1 ]
White, M. [1 ]
Perrault, L. P. [1 ]
Pellerin, M. [1 ]
Carrier, M. [1 ]
机构
[1] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada
来源
关键词
D O I
10.1016/j.healun.2005.11.230
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
221
引用
收藏
页码:S120 / S121
页数:2
相关论文
共 50 条
  • [1] Conversion to and from sirolimus in renal and hepatic transplant recipients treated with calcineurin inhibitors: Effect on renal function
    Moneim, HA
    Flechner, SM
    Goel, M
    Derweesh, IH
    Modlin, C
    Krishnamurthi, V
    Goldfarb, DA
    Novick, AC
    [J]. JOURNAL OF UROLOGY, 2005, 173 (04): : 419 - 419
  • [2] Conversion to and from sirolimus in renal and hepatic transplant recipients treated with calcineurin inhibitors: Effect on renal function.
    Moneim, HA
    Flechner, SM
    George, P
    Derweesh, IH
    Modlin, C
    Krishnamurthi, V
    Goldfarb, D
    Novick, AC
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 376 - 377
  • [3] Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus
    Backman, L
    Reisæter, AV
    Wramner, L
    Ericzon, BG
    Salmela, K
    Brattström, C
    [J]. CLINICAL TRANSPLANTATION, 2006, 20 (03) : 336 - 339
  • [4] Conversion to sirolimus with calcineurin inhibitor minimization improves renal insufficiency in pediatric heart transplant recipients
    Chinnock, Timothy J.
    Shankel, Tamara
    Cutler, Drew
    Sahney, Shobha
    Fitts, James
    Chinnock, Richard E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 570 - 570
  • [5] Effects of Conversion From Calcineurin Inhibitors to Sirolimus or Everolimus on Renal Function and Possible Mechanisms in Liver Transplant Recipients
    Tsai, Kai-Fan
    Li, Lung-Chih
    Hsu, Chien-Ning
    Lin, Chih-Che
    Lin, Yu-Hung
    Cheng, Yu-Fan
    Wang, Chih-Chi
    Chen, Chao-Long
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (03): : 326 - 334
  • [6] Sirolimus in de novo heart transplant recipients with severe renal impairment
    de Prada, JAV
    Vilchez, FG
    Cobo, M
    Ruisanchez, C
    Valls, MF
    Ruano, J
    Piñera, C
    Duran, RM
    [J]. TRANSPLANT INTERNATIONAL, 2006, 19 (03) : 245 - 248
  • [7] Early calcineurin inhibitors avoidance improves renal function in de novo heart transplant recipients: The results of a randomized controlled trial (SCHEDULE trial)
    Andreassen, A. K.
    Andersson, B.
    Gustafsson, F.
    Eiskjaer, H.
    Raadegran, G.
    Gude, E.
    Solbu, D.
    Sigurdardottir, V.
    Dellgren, G.
    Gullestad, L.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 168 - 168
  • [8] EARLY CALCINEURIN INHIBITORS AVOIDANCE IMPROVES RENAL FUNCTION IN DE NOVO HEART TRANSPLANT RECIPIENTS: THE RESULTS OF A RANDOMIZED CONTROLLED TRIAL (SCHEDULE TRIAL)
    Andreassen, Arne
    Andersson, Bert
    Eiskjaer, Hans
    Radegran, Goran
    Gustafsson, Finn
    Gude, Einar
    Jansson, Kjell
    Jansson, Kjell
    Solbu, Dag
    Sigurdadottir, Vilborg
    Dellgren, Goran
    Gullestad, Lars
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 46 - 46
  • [9] Early Calcineurin Inhibitors Elimination Improves Renal Function in De Novo Heart Transplant Recipients: The Results of a Randomized Controlled Trial (SCHEDULE Trial).
    Sigurdardottir, V.
    Andreassen, A.
    Gustafsson, F.
    Eiskjaer, H.
    Radegran, G.
    Gude, E.
    Larsson, K.
    Solbu, D.
    Andersson, B.
    Dellgren, G.
    Gullestad, L.
    [J]. TRANSPLANTATION, 2014, 98 : 3 - 3
  • [10] Early Calcineurin Inhibitors Elimination Improves Renal Function in De Novo Heart Transplant Recipients: The Results of a Randomized Controlled Trial (SCHEDULE Trial)
    Sigurdardottir, V.
    Andreassen, A.
    Gustafsson, F.
    Eiskjaer, H.
    Radegran, G.
    Gude, E.
    Larsson, K.
    Solbu, D.
    Andersson, B.
    Dellgren, G.
    Gullestad, L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 3 - 3